OUR VIEW / POINT IN TIME
The investment view
The information gain comes from whether three series keep moving together: TCV bookings, recognized revenue and full-year guidance. TCV records committed value, and multi-year terms or signing timing can lift it on their own. Recognition is what confirms the spend cleared both procurement and the revenue standard. The second marker is commercial revenue against government revenue, already near 94% in Q2. Crossing it would rewrite the company's revenue mix.
THE RESEARCH QUESTION
Are U.S. commercial customers funding AIP from innovation budgets or from the core operating plan?
Capital-expenditure disclosure long ago made upstream AI spend easy to observe. Evidence that the application layer can repeatedly win enterprise operating budgets is far thinner. Palantir is unusual in disclosing both ends of that chain: what was contracted and what was recognized. It also prices off forward sales, which puts duration at the center of the work. For a company valued that way, the margin for error lives in how long growth lasts, and a single quarter's rate explains only part of it.
FINANCIAL BRIDGE / CLAIM LEDGER
Fix the facts before debating the interpretation.
FactCL-PLTR-001
Palantir reported Q2 2026 revenue of $1.935464 billion, up 93% year over year, including U.S. commercial revenue of $764 million, up 149%.
EV-PLTR-001FactCL-PLTR-002
U.S. commercial TCV bookings reached $2.132 billion, up 153%, and FY2026 revenue guidance was raised to $8.150–8.158 billion. TCV measures total contracted commitment.
EV-PLTR-001DerivedCL-PLTR-003
On the quarter's disclosed figures, U.S. commercial revenue equals roughly 94% of U.S. government revenue ($764m / $809m), making commercial budgets a second revenue base at scale.
EV-PLTR-001CONSENSUS → EXPECTATION GAP
What the market sees—and what still needs explaining.
149% U.S. commercial growth, 153% TCV-bookings growth and another guidance raise are already in the price.
The information gain comes from whether three series keep moving together: TCV bookings, recognized revenue and full-year guidance. TCV records committed value, and multi-year terms or signing timing can lift it on their own. Recognition is what confirms the spend cleared both procurement and the revenue standard. The second marker is commercial revenue against government revenue, already near 94% in Q2. Crossing it would rewrite the company's revenue mix.
CAUSAL MECHANISM
How value travels into the income statement.
AIP lands inside the workflow
Ontology puts data, permissions and actions in one layer, so model output attaches to a specific decision.
CL-PLTR-004The budget line changes
Only when TCV, bookings and recognized revenue move together has the spend cleared procurement and recognition.
CL-PLTR-002 · CL-PLTR-004Duration gets tested
If the leading contract indicators slow first, the growth-duration assumption has to come down.
CL-PLTR-005VALUATION REGIME / REPRODUCIBLE SCENARIOS
A strong business and a good price are different questions.
Valuation here stops at enterprise-value sensitivity. The base is the company's own full-year guidance, with growth and the sales multiple written into arithmetic a reader can rebuild. Licensed point-in-time enterprise value and fully diluted share count for August 5 were not available, so no observed forward-sales multiple and no per-share conclusion appear.
Growth continuesVAL-PLTR-BASE
Takes the guidance midpoint, assumes 45% forward growth and a 24× sales multiple, and outputs enterprise value. With no verified point-in-time multiple, 24× is an assumption rather than a comparison against the tape.
8154 * 1.45 = 11823.3; 11823.3 * 24 = 283759.2Growth resetsVAL-PLTR-BEAR
At 25% growth and a 14× multiple, enterprise value lands near half the base case. The point is joint sensitivity to growth and multiple; nothing here maps to per-share value.
8154 * 1.25 = 10192.5; 10192.5 * 14 = 142695FORWARD TESTS / FALSIFIERS
What would show that the thesis is failing.
U.S. commercial revenue YoY growth < 60%
U.S. commercial growth below 60% within two quarters would mean core-budget migration is not sustaining the assumed growth duration. Sixty percent is still a high absolute rate; the line sits there so that a break has to be unambiguous.
any of the next two reported quartersU.S. commercial TCV bookings YoY growth < 50%
TCV is the leading series. If it breaks below 50% first, the alignment between contracts and recognized revenue is gone, and that alignment is the entire observable basis for the budget-migration thesis.
any of the next two reported quartersWHAT WOULD CHANGE OUR MIND
Conditions that would weaken the view.
InferenceCL-PLTR-005
If contract indicators decelerate materially ahead of revenue, the budget-migration thesis weakens first, and the tolerance embedded in a forward-sales valuation narrows at the same time.
EV-PLTR-001 · EV-PLTR-003EVIDENCE LEDGER
The interpretation is debatable. The source trail is not.
primaryEV-PLTR-001
Palantir Q2 2026 Business Update
Palantir Investor Relations · 2026-08-04 · DATA AS OF 2026-06-30
TCV is not revenue and may include multi-year commitments or timing effects.
Open primary source ↗supportingEV-PLTR-002
Palantir Q1 2026 Form 10-Q
Palantir Investor Relations · 2026-05-06 · DATA AS OF 2026-03-31
Many customer contracts contain termination-for-convenience provisions.
Open primary source ↗supportingEV-PLTR-003
Point-in-time valuation input gap
LunarTulip Research · 2026-08-05 · DATA AS OF 2026-08-05
Without a verified point-in-time enterprise value, no observed forward-sales multiple is asserted.
Enterprise value scenarios are sensitivity outputs, not observed market value or price targets.UPDATE HISTORY / DATA GAPS
Versions, revisions and what remains unknown.
Version 2.0 keeps the August 5 information set, corrects the sales-multiple arithmetic in the original draft and strips out technical levels, sizing and the remaining trading content.
Original point-in-time view: PLTR read as a strong positive sample for AI application-layer monetization.
Removed the erroneous 10–12× sales multiple, technical levels, position sizing and the HYP identifier, replacing them with primary evidence, reproducible scenario arithmetic and quantitative falsifiers.
- Licensed point-in-time enterprise value and fully diluted share count for August 5 were unavailable, so the object states no observed forward-sales multiple and no per-share value. Every sales multiple in the scenarios is an exogenous assumption.